CN1251723C - 治疗特发性血小板减少性紫癜血热病的药物组合物及制法 - Google Patents
治疗特发性血小板减少性紫癜血热病的药物组合物及制法 Download PDFInfo
- Publication number
- CN1251723C CN1251723C CN 03137085 CN03137085A CN1251723C CN 1251723 C CN1251723 C CN 1251723C CN 03137085 CN03137085 CN 03137085 CN 03137085 A CN03137085 A CN 03137085A CN 1251723 C CN1251723 C CN 1251723C
- Authority
- CN
- China
- Prior art keywords
- radix
- blood
- notoginseng
- heat
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 title claims abstract description 24
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 title claims abstract description 24
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims description 14
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 14
- 239000008280 blood Substances 0.000 title abstract description 72
- 210000004369 blood Anatomy 0.000 title abstract description 71
- 239000003814 drug Substances 0.000 claims abstract description 58
- 239000000843 powder Substances 0.000 claims abstract description 32
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 31
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 239000011505 plaster Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 3
- 238000000605 extraction Methods 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- 238000011282 treatment Methods 0.000 claims description 35
- 238000001035 drying Methods 0.000 claims description 22
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 19
- 239000008187 granular material Substances 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 235000019634 flavors Nutrition 0.000 claims description 13
- 208000019838 Blood disease Diseases 0.000 claims description 12
- 208000014951 hematologic disease Diseases 0.000 claims description 12
- 208000018706 hematopoietic system disease Diseases 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 239000002674 ointment Substances 0.000 claims description 11
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 238000011084 recovery Methods 0.000 claims description 6
- 206010013786 Dry skin Diseases 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 235000008504 concentrate Nutrition 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 235000014666 liquid concentrate Nutrition 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
- 239000000203 mixture Substances 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 12
- 206010037660 Pyrexia Diseases 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000130781 Arnebia Species 0.000 abstract 3
- 241000123589 Dipsacus Species 0.000 abstract 2
- 241000221079 Euphorbia <genus> Species 0.000 abstract 2
- 244000236658 Paeonia lactiflora Species 0.000 abstract 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 2
- 208000032843 Hemorrhage Diseases 0.000 description 21
- 230000000740 bleeding effect Effects 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 13
- 238000001816 cooling Methods 0.000 description 12
- 230000023597 hemostasis Effects 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 6
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 5
- 206010037549 Purpura Diseases 0.000 description 5
- 241001672981 Purpura Species 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 208000037920 primary disease Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 206010053567 Coagulopathies Diseases 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000035602 clotting Effects 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010014080 Ecchymosis Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000031169 hemorrhagic disease Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000009592 kidney function test Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- 238000009666 routine test Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 239000009557 Bak Foong Pill Substances 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000035992 Postmortem Changes Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000008941 guipiwan Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000012004 hematohidrosis Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000010124 zhibai dihuang Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
n | 治疗前 | 治疗后 | t值 | P | |
PtBTCTRBCWBC | 3030303030 | 53.47±18.973.93±2.183.23±1.413.91±0.524.87±1.12 | 94.57±33.723.13±1.312.57±0.734.22±0.475.87±1.55 | 30.433.782.764.593.80 | <0.01<0.01<0.01<0.01<0.01 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03137085 CN1251723C (zh) | 2003-06-18 | 2003-06-18 | 治疗特发性血小板减少性紫癜血热病的药物组合物及制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03137085 CN1251723C (zh) | 2003-06-18 | 2003-06-18 | 治疗特发性血小板减少性紫癜血热病的药物组合物及制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1565571A CN1565571A (zh) | 2005-01-19 |
CN1251723C true CN1251723C (zh) | 2006-04-19 |
Family
ID=34470343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03137085 Expired - Fee Related CN1251723C (zh) | 2003-06-18 | 2003-06-18 | 治疗特发性血小板减少性紫癜血热病的药物组合物及制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1251723C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199586B (zh) * | 2006-12-14 | 2011-12-07 | 北京因科瑞斯生物制品研究所 | 一种用于紫癜的药物 |
CN101199810B (zh) * | 2007-12-12 | 2010-10-13 | 李亚萍 | 一种治疗脾虚失统型鼻衄的中药制剂 |
CN107375738A (zh) * | 2017-07-27 | 2017-11-24 | 四川聚豪生物科技有限公司 | 一种治疗特发性血小板减少性紫癜血热病的中药组合物 |
-
2003
- 2003-06-18 CN CN 03137085 patent/CN1251723C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1565571A (zh) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1061854C (zh) | 治疗、预防妇科疾患的药物制剂 | |
CN101507776B (zh) | 一种治疗肾虚、腰膝酸软的中药制剂及其制备方法 | |
CN101095768B (zh) | 一种治疗中老年原发性高血压的中药胶囊 | |
CN102526498A (zh) | 治疗鼻咽癌放疗后毒副作用的中药、制备方法及给药方式 | |
CN1285375C (zh) | 治疗肝郁气滞型更年期综合症的中药制剂及制备方法 | |
CN1247231C (zh) | 一种产后补血保健药物及其制备方法和应用 | |
CN103341092B (zh) | 一种治疗萎缩性***炎的散剂制备方法 | |
CN104225319A (zh) | 一种治疗急性肾衰竭的中药制剂 | |
CN104524071A (zh) | 一种治疗原发性肾病的药物组合物及其用途 | |
CN100421687C (zh) | 一种治疗肾阴阳两虚的中药 | |
CN101167846A (zh) | 一种具有降糖作用的胶囊及其制备方法 | |
CN103301353B (zh) | 一种治疗萎缩性***炎的药物组合物 | |
CN105902827A (zh) | 提高人体免疫力的中药组合物及其制备方法 | |
CN1251723C (zh) | 治疗特发性血小板减少性紫癜血热病的药物组合物及制法 | |
CN103285284B (zh) | 一种治疗老年性***炎的药物组合物 | |
CN103191399A (zh) | 用于治疗支气管哮喘急性发作期的中药组合物 | |
CN103330867B (zh) | 一种治疗老年性***炎的散剂制备方法 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN110840861A (zh) | 一种通经活络颈椎贴配方及其贴剂的制备方法 | |
CN102961662B (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
CN1308024C (zh) | 一种治疗糖尿病的药物及其制备方法 | |
CN107007748A (zh) | 改善体虚症状的中药组合物、药物及其制备方法和应用 | |
CN1076622C (zh) | 一种治疗肾炎的中药 | |
CN105687765A (zh) | 一种含有拉西地平的治疗高血压的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WEIHAI SHUANGFENG INSTITUTE OF TRADITIONAL CHINESE Free format text: FORMER OWNER: LAN JINCHU Effective date: 20110919 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100054 XUANWU, BEIJING TO: 264200 WEIHAI, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110919 Address after: 264200 Shandong city in Weihai province north of Weihai high tech Industry Development Zone, Road No. -216 Patentee after: Shuangfeng Weihai Institute of traditional Chinese Medicine Address before: 100054 Beijing Xuanwu District you'anmen Street No. 72 moboyuan No. 6-301 Patentee before: Lan Jinchu |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING SANLIAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WEIHAI SHUANGFENG INSTITUTE OF TRADITIONAL CHINESE MEDICINE Effective date: 20120827 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264200 WEIHAI, SHANDONG PROVINCE TO: 100071 FENGTAI, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120827 Address after: 100071 room 139 (Park), No. 617, Fengtai junction, Beijing, Fengtai District Patentee after: Beijing Sanlian Pharmaceutical Co., Ltd. Address before: 264200 Shandong city in Weihai province north of Weihai high tech Industry Development Zone, Road No. -216 Patentee before: Shuangfeng Weihai Institute of traditional Chinese Medicine |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160607 Address after: 100062 Beijing city Dongcheng District Chongwenmen Xinyi Jiayuan 2-6-701 Patentee after: Lan Jinchu Address before: 100071 room 139 (Park), No. 617, Fengtai junction, Beijing, Fengtai District Patentee before: Beijing Sanlian Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060419 Termination date: 20200618 |
|
CF01 | Termination of patent right due to non-payment of annual fee |